Femasys Inc. (FEMY) financial statements and ratios from SEC XBRL: revenue $2.29M (TTM), net margin -812.3%, revenue growth 24.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.29M |
| Net Margin | -812.3% |
| Revenue Growth (YoY) | 24.5% |
| EPS Growth (YoY) | -100.0% |
| FCF Growth (YoY) | -13.1% |
| Price / Book | 22.37 |
| Price / Sales | 68.60 |
| FCF Yield | -11.4% |
| Altman Z-Score | -5.21 (distress) |
| Sector P/E (Healthcare) | 21.6 |
FEMY overview · FEMY earnings · FEMY KPIs · FEMY investor relations · FEMY ownership · FEMY peers · FEMY filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.